Medxtractor launches a mobile health initiative
For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) launches a mobile health (“mHealth”) initiative to apply machine-learning to predict personal health trajectories over time.
MedX reports: Where SHAMAN is a business-to-business predictive product expecting to derive revenues from researchers, practitioners and application developers, the mHealth application is envisioned as an online, consumer application that derives subscription revenues from individuals interested in their future health development. These individuals are of the same demographic that currently purchase mHealth products such as FitBit, Apple EKG and DNA test kits. Both SHAMAN and the consumer application use the Reference Database and share some predictive logic.
Jim Durward, President, states: “While developing the SHAMAN platform it became apparent that other disruptive health applications may benefit from our proprietary Reference Database. Based on our SHAMAN work, I have reason to believe there may be causal relationships that influence both mental and physical illness development, and that these relationships may allow us to predict not only the probability if an illness may develop, but also the probability of when it may develop. This mHealth initiative is called “YMI” (why-am-I). A primary goal is to provide individual health trajectories as well as allowing the individual to see how lifestyle changes may affect future health conditions. Mobile Health (“mHealth”) is predicted to grow from approximately US$50 billion this year to greater than US$160 billion over the next seven years.*”
A related video interview can be seen on the SHAMAN-AI website under “Investors/CEO Interview” OR, www.shaman-ai.com/ceo-interview
Or a slightly different one at https://youtu.be/-iOe-y-fVf8
Both SHAMAN and YMI are expected to generate revenue in late 2021.
Readers are advised that both SHAMAN and the YMI mHealth application require further development and accordingly the Corporation is not currently making any express or implied claims that the applications can, or will be able to, generate accurate results or profits.
ABOUT MEDXTRACTOR CORP:
The Corporation is a Calgary-based company that generates technologically-based solutions. The SHAMAN division is focusing on applying machine learning to predict potential benefits associated with the use of psychedelic drugs within the mental health misdiagnosis problem, and the mHealth division is developing a consumer mHealth applications. With installations all over the world, its legacy craft-scale bio-extractors are used to extract compounds from a variety of botanical materials.
FOR FURTHER INFORMATION, PLEASE CONTACT:
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: [email protected]
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.